Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

M. V. Dieci; A. Frassoldati; D. Generali; G. Bisagni; Federico Piacentini; L. Cavanna; K. Cagossi; F. Puglisi; A. Michelotti; R. Berardi; G. L. Banna; Aicha Goubar; G. Ficarra; G. Griguolo; Pierfranco Conte; V. Guarneri

doi:10.1007/s10549-017-4219-3

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

M. V. Dieci, A. Frassoldati, D. Generali, G. Bisagni, Federico Piacentini, L. Cavanna, K. Cagossi, F. Puglisi, A. Michelotti, R. Berardi, G. L. Banna, Aicha Goubar, G. Ficarra, G. Griguolo, Pierfranco Conte, V. Guarneri

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1
Number of pages	1
Journal	Breast Cancer Research and Treatment
DOIs	https://doi.org/10.1007/s10549-017-4219-3
Publication status	Accepted/In press - Apr 3 2017

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1007/s10549-017-4219-3

Cite this

Dieci, M. V., Frassoldati, A., Generali, D., Bisagni, G., Piacentini, F., Cavanna, L., Cagossi, K., Puglisi, F., Michelotti, A., Berardi, R., Banna, G. L., Goubar, A., Ficarra, G., Griguolo, G., Conte, P., & Guarneri, V. (Accepted/In press). Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials. Breast Cancer Research and Treatment, 1. https://doi.org/10.1007/s10549-017-4219-3

Dieci, MV, Frassoldati, A, Generali, D, Bisagni, G, Piacentini, F, Cavanna, L, Cagossi, K, Puglisi, F, Michelotti, A, Berardi, R, Banna, GL, Goubar, A, Ficarra, G, Griguolo, G, Conte, P & Guarneri, V 2017, 'Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials', Breast Cancer Research and Treatment, pp. 1. https://doi.org/10.1007/s10549-017-4219-3

@article{f040a4b881a04419b6670473deba34f7,

title = "Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials",

author = "Dieci, {M. V.} and A. Frassoldati and D. Generali and G. Bisagni and Federico Piacentini and L. Cavanna and K. Cagossi and F. Puglisi and A. Michelotti and R. Berardi and Banna, {G. L.} and Aicha Goubar and G. Ficarra and G. Griguolo and Pierfranco Conte and V. Guarneri",

year = "2017",

month = apr,

day = "3",

doi = "10.1007/s10549-017-4219-3",

language = "English",

pages = "1",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York LLC",

}

TY - JOUR

T1 - Erratum to

T2 - Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

AU - Dieci, M. V.

AU - Frassoldati, A.

AU - Generali, D.

AU - Bisagni, G.

AU - Piacentini, Federico

AU - Cavanna, L.

AU - Cagossi, K.

AU - Puglisi, F.

AU - Michelotti, A.

AU - Berardi, R.

AU - Banna, G. L.

AU - Goubar, Aicha

AU - Ficarra, G.

AU - Griguolo, G.

AU - Conte, Pierfranco

AU - Guarneri, V.

PY - 2017/4/3

Y1 - 2017/4/3

UR - http://www.scopus.com/inward/record.url?scp=85017008358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017008358&partnerID=8YFLogxK

U2 - 10.1007/s10549-017-4219-3

DO - 10.1007/s10549-017-4219-3

M3 - Article

AN - SCOPUS:85017008358

SN - 0167-6806

SP - 1

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

ER -

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this